新药临床试验期间药物警戒和风险控制研究六:完善新药临床试验期间药物警戒和风险控制监管体系的建议
左晓春, 冯红云, 智会静, 周凌芸, 李浩, 吕心欢, 邵颖, 杨建红, 张象麟
Research VI on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: Suggestions for Improving the Supervision System of Pharmacovigilance and Risk Control During Clinical Trail of New Drugs
Zuo Xiaochun, Feng Hongyun, Zhi Huijing, Zhou Lingyun, Li Hao, Lü Xinhuan, Shao Ying, Yang Jianhong, Zhang Xianglin
中国药事
.
2022, (6): 659
-663
.
DOI: 10.16153/j.1002-7777.2022.06.008
